1. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol. 2008; 158:69–75.
2. Carnell NE, Valente WA. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment. Thyroid. 1998; 8:647–652.
3. Chung JO, Cho DH, Chung DJ, Chung MY. Ultrasonographic features of papillary thyroid carcinoma in patients with Graves' disease. Korean J Intern Med. 2010; 25:71–76.
4. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab. 1974; 38:976–998.
5. Pacini F, Elisei R, Di Coscio GC, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A. Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest. 1988; 11:107–112.
6. Umena S, Takano T, Iijima T, Hidaka Y, Yagoro A, Takai S, Amino N. A case of repeated painless thyroiditis followed by Graves' disease. Endocr J. 1995; 42:821–826.
7. Kasuga Y, Kobayashi S, Fujimori M, Shingu K, Hama Y, Ito K, Amano J. Development of Graves' disease after surgical treatment for thyroid nodules: report of four cases. Endocr J. 1997; 44:567–570.
8. Tamai H, Hirota Y, Matsuzuka F, Kuma K, Nagataki S. Three cases developed Graves' disease after surgical treatment for thyroid carcinomas. Horumon To Rinsho. 1982; 30:124–125.
9. Nagai K, Tamai H, Matsubayashi S, Takaichi Y, Matsuzuka F, Kobayashi A, Hirai K, Kuma K, Nagataki S. A case developed Graves' disease after thyroid nodule. Horumon To Rinsho. 1987; 35:107–109.
10. Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging. 2002; 29:Suppl 2. S417–S424.
11. Misaki T, Iwata M, Kasagi K, Iida Y, Akamizu T, Kosugi S, Konishi J. Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases. Endocr J. 2000; 47:191–195.
12. Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid. Autoimmunity. 1990; 8:143–147.
13. De Bruin TW, Patwardhan NA, Brown RS, Braverman LE. Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin Exp Immunol. 1988; 72:481–485.
14. Volpe R. Autoimmune diseases of the endocrine system. Boca Raton: CRC Press;1990. Chapter 4, Immunology of the thyroid. p. 73–239.
15. Teng CS, Yeung RT, Khoo RK, Alagaratnam TT. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine. J Clin Endocrinol Metab. 1980; 50:1005–1010.
16. Nakamura S, Ishiyama-Takuno M, Kosaka J, Kondo K, Horiya Y, Hara S, Shima H, Shiraki T. A case of Graves' disease and papillary thyroid carcinoma with predominant production of thyroid-stimulation-blocking antibodies (TSBAb) persisted after total thyroidectomy. Endocrinol Jpn. 1992; 39:133–139.
17. Kiecolt-Glaser JK, Page GG, Marucha PT, MacCallum RC, Glaser R. Psychological influences on surgical recovery: perspectives from psychoneuroimmunology. Am Psychol. 1998; 53:1209–1218.
18. Bauer M. Anesthesia and perioperative immune function. Remarks on the work of M. Bauer, H. Rensing and T. Ziegenfuss (Anaesthesist 1998,47:538-556). Anaesthesist. 1998; 47:939.
19. Chung JH. Genetics of Graves' disease. J Korean Soc Endocrinol. 2003; 18:5–11.
20. Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, Matsuzuka F, Fukata S, Kuma K, Miyai K. Marked increase of CD5 + B cells in hyperthyroid Graves' disease. Clin Exp Immunol. 1989; 78:196–200.